Zymeworks (NYSE: ZYME) reported Q3 EPS of ($0.66), $0.23 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $5.55 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.